Dataset Information


EDTA Treatment for Overcoming the Prozone Effect and for Predicting C1q Binding in HLA Antibody Testing.

ABSTRACT: The Luminex-based single antigen bead (SAB) assay is widely used to detect HLA antibody in transplant recipients. However, one limitation of the SAB assay is the prozone effect, which occurs mostly as a result of complement interference. We investigated the efficacy of EDTA treatment for overcoming the prozone effect and predicting C1q binding of HLA antibody. We subjected 27 non-treated (naïve) and EDTA-treated serum samples from highly sensitized patients to IgG-SAB assays, and we confirmed the prozone effect in 53% and 31% of class I and class II antibody tests, respectively, after EDTA treatment. When we conducted additional assays after dithiothreitol treatment and serum dilution, EDTA was the most efficacious in eliminating the prozone effect. Reducing the prozone effect by EDTA treatment strengthened the correlation between IgG mean fluorescence intensity (MFI) and C1q MFI values (ρ=0.825) as compared with the naïve sera (ρ=0.068). Although C1q positivity was dependent on the concentration of HLA antibody in EDTA-treated sera, the correlations varied individually. Overall, our results confirmed the efficacy of EDTA treatment for overcoming the prozone effect. EDTA treatment showed a positive effect on the correlation between IgG MFI and C1q MFI values.


PROVIDER: S-EPMC6660344 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC5457814 | BioStudies
2019-01-01 | S-EPMC6687874 | BioStudies
1000-01-01 | S-EPMC4696574 | BioStudies
2018-01-01 | S-EPMC6817106 | BioStudies
2017-01-01 | S-EPMC5291387 | BioStudies
2017-01-01 | S-EPMC5540632 | BioStudies
2020-01-01 | S-EPMC7591533 | BioStudies
2017-01-01 | S-EPMC5671504 | BioStudies
1000-01-01 | S-EPMC5682763 | BioStudies
2014-01-01 | S-EPMC6741594 | BioStudies